Zhejiang Jianfeng Group Co., Ltd. (SHA:600668)

China · Delayed Price · Currency is CNY

7.42

-0.12 (-1.59%)

Jun 16, 2026, 2:45 PM CST

-36.58% (1Y)

Market Cap	3.10B -38.3%
Revenue (ttm)	2.52B -11.8%
Net Income	-188.70M
EPS	-0.45
Shares Out	410.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (1.33%)
Ex-Dividend Date	Jul 15, 2025

Volume	3,577,414
Open	7.54
Previous Close	7.54
Day's Range	7.37 - 7.58
52-Week Range	7.27 - 13.47
Beta	0.42
Analysts	Buy
Price Target	10.00 (+34.77%)
Earnings Date	Aug 25, 2026

About Zhejiang Jianfeng Group

Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and pharmaceuticals business in China. The company offers pharmaceutical products, including antibiotics, cardiovascular drugs, antidepressants, ophthalmic drugs, anti-tumor drugs, and infant medications. It is involved in investment in pharmaceutical and healthcare industries; manufacturing and sales of cement and cement concrete; production and sales of pharmaceutical intermediates; sales of pharmaceutical chemical raw materials; and import and export business; and other indu... [Read more]

Industry Building Materials

Sector Materials

Founded 1958

Employees 1,836

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600668

Full Company Profile

Financial Performance

In 2025, Zhejiang Jianfeng Group's revenue was 2.57 billion, a decrease of -10.74% compared to the previous year's 2.88 billion. Earnings were 411.90 million, an increase of 281.43%.

Financial Statements